Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Sept 2025 for Jasper Therapeutics, Inc., €84k. Read the official filing
Filing timeline
BuySaleRon Martell
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ron Martell: trading record in brief
All filings by Ron Martell on record concern Jasper Therapeutics, Inc. We count 4 filings; the first trade dates from 12 October 2022 and the latest from 22 September 2025.
No open-market sale appears; the market trades are 1 purchase worth €84k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants. Since January 2025: 1 purchase and no sales on the market.
On 24 September 2025 came the latest disclosure, an open-market purchase for €84k in Jasper Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ron Martell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
41,000 shares@ US$2.4331.1% of flowVoting Common StockSEC:0001213900-25-091099:0
Canonical exit: 21 Dec 2025 (T+90)
87,531 shares@ US$0.8526.0% of flowVoting Common StockSEC:0001013762-23-003902:0
87,531 shares@ US$1.4642.8% of flowVoting Common StockSEC:0001213900-23-029896:0
506,250 shares0Voting Common StockSEC:0001213900-22-063949:0
4 of 4 declarations
